EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantum and Artificial Intelligence in Drugs and Pharmaceutics

Bruno F. E. Matarèse

BioChem · 14.01.2026 · 6 (1) · 2

DOI: 10.3390/biochem6010002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioChem, online erschienen am 14.01.2026. Verfasst von Bruno F. E. Matarèse. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 426 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmaceutical industry faces a broken drug development pipeline, characterized by high costs, slow timelines and is prone to high failure rates. The convergence of Artificial Intelligence (AI) and quantum technologies is poised to fundamentally transform this landscape. AI excels in interpreting complex data, optimizing processes and designing drug candidates, while quantum systems enable unprecedented molecular simulation, ultra-sensitive sensing and precise physical control. This convergence establishes an integrated, self-learning ecosystem for the discovery, development, and delivery of therapeutics. This framework co-designs strategies from molecular targeting to formulation stability, compressing timelines and enhancing precision, which may enable safer, faster, and more adaptive medicines.

Zitieren

APA

Matarèse, B. F. E. (2026). Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem, 6(1), 2. https://doi.org/10.3390/biochem6010002

Vancouver

Matarèse BFE. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem. 2026;6(1):2. doi:10.3390/biochem6010002

BibTeX
@article{Matarse2026,
  author = {Matarèse, Bruno F. E.},
  title = {Quantum and Artificial Intelligence in Drugs and Pharmaceutics},
  journal = {BioChem},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {2},
  doi = {10.3390/biochem6010002}
}
Kostenlos starten →